Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Continuing Operations
Net loss from continuing operations	$ (40,523)	$ (130,854)
Adjustments to reconcile net loss from continuing operations to net cash used in continuing operating activities:
Impairment of goodwill and other intangible assets	10,468	28,995
Depreciation	2,029	1,275
Amortization of intangible assets		2,752
Amortization of Convertible Debenture discount		9,253
Interest on convertible debt paid-in-kind		8,257
Share-based compensation	1,763	8,629
Change in fair value of warrant liabilities	(35,903)	19,608
Change in fair value of derivative liabilities	(721)
Deferred income taxes
Amortization of deferred financing costs and discounts	4,715	1,143
Net gain on sale of certain rights to software	(1,708)
Noncash financing fees	4,650	5,948
Loss on disposal of property and equipment	54	2
Changes in operating assets and liabilities:
Accounts receivable	1,085	(5,327)
Prepaid expenses and other current assets	(4,261)	(1,530)
Accounts payable and accrued expenses	(5,848)	6,761
Deferred revenue	(48)	(189)
Other	155	(2,075)
Net cash used in continuing operating activities	(64,093)	(47,352)
Cash Flows from Continuing Investing Activities:
Proceeds from sale of certain rights to software	2,500
Purchase of property and equipment	(266)	(2,990)
Proceeds from sale of property and equipment		1
Deferred development costs	(917)	(931)
Net cash provided by (used in) continuing investing activities	1,317	(3,920)
Cash Flows from Continuing Financing Activities:
Net change in line of credit		(7,355)
Payment of taxes from withheld shares	(48)	(1,148)
Debt repayments	(27,528)	(6,525)
(Repayment of) proceeds from promissory note - related party	(5,000)	5,000
Proceeds from issuance of debt		27,000
Redemption of Series B Preferred Stock paid in cash	(1,344)
Proceeds from issuance of Convertible Debentures (See Note 10)		24,000
Proceeds from the issuance of securities	23,664	27,784
Proceeds from issuance of Series B Preferred Stock and February 2022 Warrants (See Note 10)	15,000
Proceeds from issuance of Convertible Note (See Note 10)	10,000
Payment for fractional shares	(55)
Proceeds from exercise of certain warrants	4	5,002
Payment of deferred financing fees	(1,202)	(1,872)
Net cash provided by continuing financing activities	13,491	71,886
Cash Flows from Discontinued Operations
Net cash (used in) provided by operating activities	(5,291)	5,148
Net cash provided by (used in) investing activities	31,948	(1,012)
Net cash provided by discontinued operations	26,657	4,136
Net change in cash	(22,628)	24,750
Cash, beginning of period	35,255	10,505
Cash, end of period	12,627	35,255
Supplemental Disclosures about Cash Flow Information
Cash paid for interest	7,896	1,058
Cash paid for income taxes	342	266
Supplemental Schedule of Noncash Investing and Financing Activities
Series B Preferred Stock converted to common stock	4,640
Convertible Notes converted to common stock	11,672
Conversion of an amount from accounts payable to note payable	2,427
Initial recognition of right-of-use asset on adoption of ASC 842 (See Note 7)	592
Initial recognition of operating lease liability on adoption of ASC 842 (See Note 7)	592
Noncash conversion of Debentures to common stock		109,695
Fair value of Penny Warrants related to the issuance of Convertible Debentures		9,223
Capital expenditures included in accounts payable and accrued expenses		64
Noncash conversion of Series A Preferred to common stock		$ 12,456